Opdivo 240 MG/24 ML vial 24ML
Ended Awarded
- Contract number
- SPE2DB25FDANV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,689
Award facts
- Contract value 100% obligated
- $49,689.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on September 16, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of Opdivo 240 mg/24 mL vials with a ceiling value of $49,689.30 and a firm fixed price structure. The award represents a competitive procurement with no set-aside designation, with performance to be completed by October 7, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which functions as a comprehensive global pharmaceutical support vehicle.
The DLA Troop Support Medical contract provides AmerisourceBergen with authorization to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. This arrangement enables the company to efficiently serve multiple federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard. The current delivery order for Opdivo—a premium oncology treatment—underscores the critical role pharmaceutical distributors play in ensuring military medical readiness and access to specialized therapeutic agents for service members and their families.
Quick answers
Who was awarded contract SPE2DB25FDANV?
SPE2DB25FDANV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FDANV worth?
The government has obligated $49,689 on SPE2DB25FDANV.
Is contract SPE2DB25FDANV an order under another contract?
Yes. SPE2DB25FDANV is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB25FDANV competed?
The extent of competition for SPE2DB25FDANV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award